Phase I trial of PL 3994 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 23 Sep 2008
At a glance
- Drugs PL 3994 (Primary)
- Indications Chronic heart failure; Heart failure
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Palatin Technologies
- 23 Sep 2008 Results reported at the 12th Annual Scientific Meeting of the Heart Failure Association of America, 2008.
- 23 Sep 2008 Primary endpoint 'Blood pressure' has been met, according to a Palatin media release.
- 14 Aug 2008 Results will be presented at the Annual Scientific Meeting of the Heart failure Society of America in September 2008.